Investor

The company will use the funds to expand nationally, enhance its technology platform and advance clinical innovation.

The funds will be used to expand its direct-to-consumer services and grow partnerships with payers and health systems.

The round follows a $200 million seed raise earlier this year.

The funding round comes one month after the company announced it secured a $35 million investment.

The funds will be used to expand the company's reach with payers and providers, grow its team and for product development.

The company is on track to be live in 10 U.S. states by the end of 2025.

Dr. Atul Gupta, CMO of diagnosis and treatment at Philips, and Kevin Roesch, assistant VP of cardiology and imaging services for Methodist Hospitals, highlight the process of developing interventional labs to support Indiana’s residents.

The company will use the funds to improve its value-based care model, including its AI and analytics tools, and expand its partnerships and services.

The company will use the funding to further develop its SmartShunt System, aimed at reducing shunt failures and improving care for patients with hydrocephalus.

The company will use the funds to expand access to its AI-driven platform that allows providers to access and organize patient medical records.